GlassScriptPhysician profile
Thuha N Pham
NPI 1598908410
$8,771.80
in general payments reported to CMS, 2019-2025
47 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $1,456 · 2021: $1,587 · 2022: $986 · 2023: $449 · 2024: $2,744 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179 · Travel and Lodging: $1,453 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,179.33 |
| Travel and Lodging | $1,453.49 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,001.83 | 2024 | Indigo System |
| Viiv Healthcare Company | $707.25 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $675.05 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $631.97 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $523.33 | 2019-2022 | |
| Abbvie INC. | $496.12 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.92 | 2019-2023 | Jardiance |
| Amgen INC. | $249.14 | 2019-2025 | Evenity, Prolia, Repatha |
| Philips North America LLC | $217.86 | 2024 | (Bh4) Igt Devices Undivided, (P84) Igt Devices Systems |
| Eisai INC. | $216.75 | 2020-2022 | |
| Amarin Pharma, INC. | $192.43 | 2019-2021 | |
| Janssen Biotech, INC. | $186.22 | 2019-2022 | |
| Lilly USA, LLC | $168.64 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Genentech USA, INC. | $160.10 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $141.20 | 2019-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thuha Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.